Harbin Medisan Pharmaceutical Co., Ltd. (SHE:002900)
China · Delayed Price · Currency is CNY 15.30
-0.33 (-2.11%)
Aug 20, 2026, 3:04 PM CST
SHE:002900 Revenue
Harbin Medisan Pharmaceutical had revenue of 228.84M CNY in the quarter ending March 31, 2026, with 11.61% growth. This brings the company's revenue in the last twelve months to 813.23M, down -25.44% year-over-year. In the year 2025, Harbin Medisan Pharmaceutical had annual revenue of 789.42M, down -30.29%.
Revenue (ttm)
813.23M
Revenue Growth
-25.44%
P/S Ratio
6.08
Revenue / Employee
389.85K
Employees
2,086
Market Cap
4.94B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 789.42M | -343.05M | -30.29% |
| Dec 31, 2024 | 1.13B | -54.31M | -4.58% |
| Dec 31, 2023 | 1.19B | 158.37M | 15.40% |
| Jan 1, 2023 | 1.03B | 82.61M | 8.73% |
| Jan 1, 2022 | 945.80M | -393.08M | -29.36% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jan 1, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.